Study Summary
A Study of NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia.
Interested in this trial?
Submit an InquiryInterventions
NKG2D CAR T-cellsDRUG
Each subject receive NKG2D CAR T-cells by intravenous infusion
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| The First Affiliated Hospital，College of Medicine, Zhejiang University | Hangzhou | Zhejiang | China |